Lancet Market Research Report - Global Forecast till 2027

Global Lancet Market by Type (Safety Lancet, Personal Lancet), End User (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others) and Region - Forecast till 2027

ID: MRFR/MED/1546-CR | May 2019 | Region: Global | 106 pages

Please note that the assessment period of report has been updated from 2019-2024 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview:


In recent times lancets have gained market due to their use in glucose or diabetes testing, heel-stick screening tests, tests in infants, severely burned patients, and scarred emergency patients. With a rise in the incidence rate of non-contagious and contagious diseases the market has seen an exponential boom.


A great number of diabetic populations have benefitted from the functionality and application of lancets. As per the study from CDC (Disease Control and Prevention), more than 9.4% of people around the US are diagnosed with diabetes which makes lancets gain market in the region. With the increasing prevalence of diabetes, awareness about healthy lifestyle, government's initiatives to spread diabetes awareness is making the market for lancets product and devices which are people-friendly and easy to use at home.


A few of the factors responsible for the growth of the market are home diagnostics, home care, and other factors rising people interest in-home care systems. Blood transfusion comes with high risk and is not permitted to be practiced at home. This might lead to people being less willing to adapt to lancets and cause a hindrance in the market growth.


The global Lancet Market is expected to generate a revenue of more than 1500 million US dollars during the forecast year 2024. The global Lancet Market is expected to register a CAGR of more than 10.50% by the end of the forecast year 2024.


  


COVID-19 Analysis:


The sudden increase of the coronavirus pandemic, the waves, and the increasing rate of fatality by each passing wave is a major matter of concern. Though the demand for healthcare products, sanitizers, immunity boosters, major vitamins for the body, and medicines is increasing, the market is facing a major issue in developing medicines and vaccines that are applicable for all the virus strains. The first wave of the pandemic in 2020 portrayed that the coronavirus was deadly for all those who have diabetes and blood pressure issues. Hence, the demand for the global Lancet market trends experienced a steep boost. 


The government along with the healthcare sectors and developers of pharmaceuticals is eyeing to develop product portfolios. These are going to help in proper detection and benefit the patients suffering from diabetes around the globe. Also, the key market players are increasing their investment in the research and development areas to benefit the target audience and emerge as a dominant force in the market by the end of the global forecast period.


 


Market Dynamics:


Drivers:


The factors responsible for the increase in the lancets market of devices and products are diabetes being the global scourge with an expectation of more than 600 million people affected with diabetes by 2040, rise in diabetes in senior citizens, increase in the number of obese people, children being succumbed to diabetes, need to monitor glucose level with the threat of worse scenarios, awareness about healthy lifestyle, government's initiatives to spread diabetes awareness, use of lancets in glucose or diabetes testing, heel-stick screening tests, tests in infants, severely burned patients, and scarred emergency patients, rise in the incidence rate of non-contagious and contagious diseases, rise in home diagnostics, home care, and other factors rising people interest in-home care systems, availability of reimbursement options, and Others.


 


Challenges:


Blood transfusion comes with high risk and is not permitted to be practiced at home. This might lead to people being less willing to adapt to lancets and cause a hindrance in the lancet market growth. Other factors responsible for restraining the market growth are lack of awareness within patients, high cost of replacement of the lancet devices, undiagnosed cases which can be life-threatening.


Technology Analysis:


With diabetes being the global scourge, capillary blood sampling is done using blood sugar lancets which are small medical devices like a scalpel with a double-edged blade or needle to take a blood sample and test it against the sugar levels and determine the stage of diabetes. Minuscule punctures are made in the human body generally the index finger of the hand to take blood samples in the disposables.


With the increasing prevalence of diabetes, awareness about healthy lifestyle, government's initiatives to spread diabetes awareness is making the market for lancets product and devices which are people-friendly and easy to use at home. Lancets have gained market due to their use in glucose or diabetes testing, heel-stick screening tests, tests in infants, severely burned patients, and scarred emergency patients. 


With a rise in the incidence rate of non-contagious and contagious diseases the market has seen an exponential boom. A few of the factors responsible for the growth of the market are home diagnostics, home care, and other factors rising people interest in-home care systems. Blood transfusion comes with high risk and is not permitted to be practiced at home. This might lead to people being less willing to adapt to lancets and cause a hindrance in the lancet market growth.


Global Lancet Market Revenue, by End User (USD Million)  Lancet Market_TOC


Source: MRFR Analysis


Study Objectives:


- The global Lancet market research report aims to study the market trends and dynamics, along with the opinion of the market leaders and industry experts to predict a CAGR growth for the market. 


- The report covers the recent developments to help the market and draw a competitive market landscape for the key market players exiting and entering the global lancet market.


- The industry also discusses the initiatives by the key players in the global and international market


Segment Overview:



By Product Outlook:


The global lancet market is segmented based on product outlook as Specialty Lancets, Standard Lancets, Personal Lancet, and Safety Lancets (Pressure Activated Safety Lancet, Push Button Safety Lancet, and Side Button Safety Lancet).



By Application Outlook:


The global lancet market is segmented based on application outlook as Hemoglobin Testing, Coagulation Testing, Blood Glucose Testing, Cholesterol Testing, and Other Application.



By End User:


The global lancet market is segmented based on end-user as Hospitals, Clinics, Home Diagnostics, Pathology Laboratories, Diagnostic Centers, Research Laboratories, Academic Laboratories, and Others.


Global Lancet Market Share, 2018 (%)  Lancet Market_TOC


Source: MRFR Analysis



Regional Analysis:


The global lancet market is segmented based on region as Europe (Spain, Italy, Germany, UK, France, and the Rest of Western Europe), the Americas (North America (The US and Canada) and Latin America (Mexico and Brazil)), Asia-Pacific (Australia, China, Japan, South Korea, India, and the Rest of Asia-Pacific), The Middle East, Africa, and South Africa.


Europe is the world-dominant in terms of market share and revenue of the global lancet market. The European lancet market has seen exceptional growth in the recent year due to an increase in demand for safety tests of blood glucose at clinics, hospitals, diagnostics centers, and others, and a rise in demand of the insulin users. America accounted for the second position in the world's leading companies due to the rise in obese people, the rise in the population with diabetes, and the need to be proactive about it. Asia-Pacific has seen an immense rise in the lancet market due to low labor cost and low manufacturing cost in the area of developing countries.


With the lack of adequate expenditure in the healthcare department in the regions of The Middle East and Africa, the lancet market is least expected to grow there.



Competitive Landscape:


The Competitive Landscape of the lancet device market studies the key strategies of the major market players. The study also analyzes the product development, innovation, new product launches, Industry Trends, Technology Assessment, Technology Trends, acquisition, and mergers done by the industrial experts.


The Intended Audience of the lancet device market is Research Organizations, Pharmaceutical Companies, Academic Institutes, and Development Organizations.


The key players of the global lancet market are HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), Becton Dickinson and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Improve Medical Instruments Co. Ltd (US), Bayer AG (Germany), Sarstedt AG & Co. (Germany), 


Abbott Laboratories (US), Greiner Bio-One International GmbH (US), and others.


Recent Developments:


- In October 2017, the US Food and Drug Organization Administration approved Abbott Laboratories’ innovation by the name of The Freestyle Libre Flash which was Glucose Monitoring Systems that helped monitor glucose or sugar levels in adults. This helped company develop a better portfolio by offering advanced products by the company.


- In August 2017, safety lancets were donated by HTL-STREFA S.A. to an organization in Poland i.e. GLOBAL-MED. This initiative was called Ambulans-z-serca or Ambulance from the heart that helped in free glucose screenings in moving vehicles during various healthcare events. By expanding its customer base, the company intended to strengthen its global market prevalence.


- In April 2017, C. R. Bard Inc. was acquired by Becton Dickinson and Company to strengthen the company's portfolio by offering new and advanced products in the areas of vascular, surgical specialty products, urology, and oncology.



Report Overview:


The global Lancet market research report discusses the market dynamics and opportunities that are likely to play an important role in helping the market reach the projected market valuation. Also, the report discusses the market segmentation and its functioning in various geographies of the world. The market has major growth opportunities for various regions like the APAC region, and the North American region to emerge as the dominant forces. The report also discusses the recent market developments and the key strategies taken by prominent market players to help the market grow by the end of the global forecast period.



Frequently Asked Questions (FAQ) :


Lancet Market valuation was USD 1595.5 million in 2018.

The projected CAGR would be USD 1595.5 million during the forecast period.

Risk regarding the blood transfusion process can prevent the market from having regular growth.

The hospitals and clinics segment would dominate.

Europe would enjoy the largest market share.

1 Executive Summary

2 Market Introduction

2.1 Definition 18

2.2 Scope of the Study 18

2.3 Market Structure 18

3 Research Methodology

3.1 Research Process 19

3.2 Primary Research 20

3.3 Secondary Research 21

3.4 Market Size Estimation 22

3.5 Forecast Model 22

4 Market Dynamics

4.1 Overview 23

4.2 Drivers 23

4.2.1 Improving Medical Device Regulations 23

4.2.2 Growing Incidence of Contagious and Non-Contagious Diseases 24

4.2.3 Increasing Prevalence of Diabetes 24

4.2.4 Increasing Inclination Towards Home Healthcare 24

4.3 Restraints 25

4.3.1 Risk Associated with Blood Transfusion 25

6 Market Factor Analysis

5.1 Porter’s Five Forces Model 26

5.1.1 Bargaining power of suppliers 27

5.1.2 Bargaining Power of Buyers 27

5.1.3 Threat of New Entrants 27

5.1.4 Threat of Substitutes 27

5.1.5 Intensity of Rivalry 27

5.2 Supply Chain Analysis 28

7 Global Lancet Market by Type

6.1 Overview 29

6.2 Safety Lancet 30

6.2.1 Push Button Safety Lancet 30

6.2.2 Pressure Activated Safety Lancet 30

6.2.3 Side Button Safety Lancet 30

6.3 Personal Lancet 32

8 Global Lancet Market by End User

7.1 Overview 33

7.2 Hospitals & Clinics 35

7.3 Diagnostic Centers and Pathology Laboratories 36

7.4 Home Diagnostics 37

7.5 Research and Academic Laboratories 38

9 Global Lancet Market by Region

8.1 Overview 39

8.2 Europe 41

8.2.1 Western Europe 43

8.2.1.1 Poland 46

8.2.1.2 Germany 47

8.2.1.3 France 49

8.2.1.4 UK 50

8.2.1.5 Italy 52

8.2.1.6 Rest of Western Europe 53

8.2.2 Eastern Europe 55

8.3 Americas 57

8.3.1 North America 59

8.3.1.1 US 61

8.3.1.2 Canada 63

8.3.2 Latin America 64

8.4 Asia-Pacific 66

8.4.1 Japan 68

8.4.2 China 70

8.4.3 India 71

8.4.4 South Korea 73

8.4.5 Rest of Asia-Pacific 74

8.5 Middle East and Africa 76

8.5.1 UAE 78

8.5.2 Saudi Arabia 80

8.5.3 Egypt 81

8.5.4 Rest of Middle East and Africa 83

10 Competitive Landscape

9.1 Overview 85

9.2 Company Share Analysis 85

9.3 Pricing of Lancets 86

9.4 Production Capacity of Major Players 86

11 Company Profile

10.1 Terumo Corporation 87

10.1.1 Company Overview 87

10.1.2 Financial Overview 87

10.1.3 Products/Services Offering 88

10.1.4 Key Developments 88

10.1.5 SWOT Analysis 88

10.1.6 Key Strategies 88

10.2 Bayer AG 89

10.2.1 Company Overview 89

10.2.2 Financial Overview 89

10.2.3 Products/Services Offering 90

10.2.4 Key Developments 90

10.2.5 SWOT Analysis 90

10.2.6 Key Strategies 90

10.3 HTL-STREFA S.A. 91

10.3.1 Company Overview 91

10.3.2 Financial Overview 91

10.3.3 Products/Services Offering 91

10.3.4 Key Developments 92

10.3.5 SWOT Analysis 92

10.3.6 Key Strategies 92

10.4 Sarstedt AG & Co. 93

10.4.1 Company Overview 93

10.4.2 Financial Overview 93

10.4.3 Products/Services Offering 93

10.4.4 Key Developments 93

10.4.5 SWOT Analysis 94

10.4.6 Key Strategies 94

10.5 Becton, Dickinson and Company 95

10.5.1 Company Overview 95

10.5.2 Financial Overview 95

10.5.3 Products/Services Offering 96

10.5.4 Key Developments 96

10.5.5 SWOT Analysis 97

10.5.6 Key Strategies 97

10.6 Abbott Laboratories 98

10.6.1 Company Overview 98

10.6.2 Financial Overview 98

10.6.3 Products/Services Offering 99

10.6.4 Key Developments 99

10.6.5 SWOT Analysis 99

10.6.6 Key Strategies 99

10.7 F. Hoffmann-La Roche Ltd 100

10.7.1 Company Overview 100

10.7.2 Financial Overview 100

10.7.3 Products/Services Offering 101

10.7.4 Key Developments 101

10.7.5 SWOT Analysis 101

10.7.6 Key Strategies 101

10.8 Greiner Bio One International GmbH 102

10.8.1 Company Overview 102

10.8.2 Financial Overview 102

10.8.3 Products/Services Offering 103

10.8.4 Key Developments 103

10.8.5 SWOT Analysis 103

10.8.6 Key Strategies 103

10.9 Improve Medical Instruments Co. Ltd 104

10.9.1 Company Overview 104

10.9.2 Financial Overview 104

10.9.3 Products/Services Offering 104

10.9.4 Key Developments 104

10.9.5 SWOT Analysis 104

10.9.6 Key Strategies 105

12 Appendix

11.1 References 106

11.2 Related Reports 106

13 List of Tables

TABLE 1 GLOBAL LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 30

TABLE 2 GLOBAL LANCET MARKET FOR SAFETY LANCET, BY REGION, 2020–2027 (USD MILLION) 31

TABLE 3 GLOBAL LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 31

TABLE 4 GLOBAL LANCET MARKET FOR PERSONAL LANCET, BY REGION, 2020–2027 (USD MILLION) 32

TABLE 5 GLOBAL LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 34

TABLE 6 GLOBAL LANCET MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 35

TABLE 7 GLOBAL LANCET MARKET FOR DIAGNOSTIC CENTERS AND PATHOLOGY LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 8 GLOBAL LANCET MARKET FOR HOME DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 9 GLOBAL LANCET MARKET FOR HOME DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 10 GLOBAL LANCET MARKET, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 11 EUROPE: LANCET MARKET, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 12 EUROPE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 13 EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 14 EUROPE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 43

TABLE 15 WESTERN EUROPE: LANCET MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 44

TABLE 16 WESTERN EUROPE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 17 WESTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 18 WESTERN EUROPE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 45

TABLE 19 POLAND: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 20 POLAND: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 21 POLAND: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 47

TABLE 22 GERMANY: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 23 GERMANY: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 24 GERMANY: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 48

TABLE 25 FRANCE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 26 FRANCE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 27 FRANCE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 50

TABLE 28 UK: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 50

TABLE 29 UK: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 30 UK: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 51

TABLE 31 ITALY: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 32 ITALY: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 33 ITALY: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 53

TABLE 34 REST OF WESTERN EUROPE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 35 REST OF WESTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 36 REST OF WESTERN EUROPE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 54

TABLE 37 EASTERN EUROPE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 38 EASTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 39 EASTERN EUROPE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 56

TABLE 40 AMERICAS: LANCET MARKET, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 41 AMERICAS: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 42 AMERICAS: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 43 AMERICAS: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 59

TABLE 44 NORTH AMERICA: LANCET MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 60

TABLE 45 NORTH AMERICA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 46 NORTH AMERICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 47 NORTH AMERICA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 61

TABLE 48 US: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 49 US: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 50 US: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 51 CANADA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 52 CANADA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 53 CANADA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 54 LATIN AMERICA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 55 LATIN AMERICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 56 LATIN AMERICA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 57 ASIA-PACIFIC: LANCET MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66

TABLE 58 ASIA-PACIFIC: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 59 ASIA-PACIFIC: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 60 ASIA-PACIFIC: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 68

TABLE 61 JAPAN: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 62 JAPAN: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 63 JAPAN: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 64 CHINA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 65 CHINA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 66 CHINA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 67 INDIA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 68 INDIA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 69 INDIA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 72

TABLE 70 SOUTH KOREA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 71 SOUTH KOREA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 72 SOUTH KOREA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 73 REST OF ASIA-PACIFIC: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 74 REST OF ASIA-PACIFIC: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 75 REST OF ASIA-PACIFIC: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 75

TABLE 76 MIDDLE EAST AND AFRICA: LANCET MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76

TABLE 77 MIDDLE EAST AND AFRICA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 78 MIDDLE EAST AND AFRICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 79 MIDDLE EAST AND AFRICA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 78

TABLE 80 UAE: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 81 UAE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 82 UAE: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 83 SAUDI ARABIA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 84 SAUDI ARABIA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 85 SAUDI ARABIA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 86 EGYPT: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 87 EGYPT: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 88 EGYPT: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 82

TABLE 89 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 90 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 91 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 92 LANCET PRICE INFORMATION 86

TABLE 93 PRODUCTION CAPACITY 86

14 List of Figures

FIGURE 1 FDA TIME LINE FOR LANCETS 14

FIGURE 2 MARKET SYNOPSIS 15

FIGURE 3 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL LANCET MARKET 16

FIGURE 4 GLOBAL LANCET SHARE, BY TYPE, 2020 (%) 16

FIGURE 5 GLOBAL LANCET MARKET, BY TYPE, 2020–2027 (USD MILLION) 17

FIGURE 6 GLOBAL LANCET MARKET SHARE, BY END USER, 2020 (%) 17

FIGURE 7 GLOBAL LANCET MARKET, BY END USER, 2020–2027 (USD MILLION) 17

FIGURE 8 GLOBAL LANCET MARKET: MARKET STRUCTURE 18

FIGURE 9 RESEARCH PROCESS OF MRFR 19

FIGURE 10 TOP-DOWN & BOTTOM-UP APPROACH 22

FIGURE 11 MARKET DYNAMICS: GLOBAL LANCET MARKET 23

FIGURE 12 PORTERS FIVE FORCES MODEL 26

FIGURE 13 SUPPLY CHAIN ANALYSIS 28

FIGURE 14 GLOBAL LANCET MARKET, BY TYPE, 2020 (%) 29

FIGURE 15 GLOBAL LANCET MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 29

FIGURE 16 GLOBAL LANCET MARKET, BY END USER, 2020 (%) 33

FIGURE 17 GLOBAL LANCET MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 33

FIGURE 18 GLOBAL LANCET MARKET, BY REGION, 2020 (%) 39

FIGURE 19 GLOBAL LANCET MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 40

FIGURE 20 EUROPE: LANCET MARKET, BY REGION, 2020–2027 41

FIGURE 21 WESTERN EUROPE: LANCET MARKET, BY COUNTRY, 2020–2027 43

FIGURE 22 AMERICAS: LANCET MARKET, BY REGION, 2020–2027 57

FIGURE 23 NORTH AMERICA: LANCET MARKET, BY COUNTRY, 2020–2027 59

FIGURE 24 ASIA-PACIFIC: LANCET MARKET, BY COUNTRY, 2020–2027 66

FIGURE 25 MIDDLE EAST AND AFRICA: LANCET MARKET, BY COUNTRY, 2020–2027 76

FIGURE 26 GLOBAL LANCET MARKET SHARE ANALYSIS, 2020 (%) 85